#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Paraneoplastic neurological syndrome Cholestatic pruritus Small cell lung cancer limited stage Acute graft versus host disease in skin Cervix carcinoma Pulmonary alveolar haemorrhage Allogenic stem cell transplantation Warm autoimmune haemolytic anaemia Measles Mitochondrial encephalomyopathy Cutaneous calcification Mucopolysaccharidosis I Autoimmune disorder Phaeochromocytoma Leukodystrophy More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage III – Treatment Inclusion body myositis – Diagnostics Isodicentric chromosome 15 syndrome – Trials in Disease Angiosarcoma recurrent – Basic Information Pulmonary fibrosis – Basic Information Carcinoid syndrome – Basic Information Nodal marginal zone B-cell lymphoma – Diagnostics Mucopolysaccharidosis – Basic Information Kearns-Sayre syndrome Leiomyosarcoma metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ima203Cd8 ANXV Ulipristal Acetate Colecalciferol Ligelizumab LINAPRAZAN GLURATE Nilotinib AZD1163 Xylitol Ilofotase Alfa Ramipril Rosuvastatin Calcium COBALAMIN Brodalumab Exemestane Vepdegestrant Interferon Alfa Floxuridine Tolinapant Lactate Fluoxetine Hydrochloride More therapies…

    Learn about Your Condition

    Aphthous ulcer Necrotising myositis Cirrhosis alcoholic Hereditary optic atrophy Micrographic skin surgery Habitual abortion Major depression Coronary artery bypass Epileptic encephalopathy Choreoathetosis Foot deformity Respiratory failure Sepsis Transitional cell carcinoma Follicular lymphoma stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Evangelisches Waldkrankenhaus Spandau Krankenhausbetriebs…

Evangelisches Waldkrankenhaus Spandau Krankenhausbetriebs gGmbH

Stadtrandstrasse 555-561/2, Spandau, Berlin, 13589, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Treating Knee Osteoarthritis with Nasal Cartilage Implantation for Patients with Patellofemoral Osteoarthritis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • N-Tec
    Austria Croatia Germany Italy The Netherlands Poland +1

  • Study of BP CC 001 stem cells from umbilical cord tissue for treating knee cartilage damage

    Recruiting

    2 1 1
    Investigated Diseases:
    • Chondropathy
    Germany

  • Study on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colon cancer stage III
    • Colon cancer stage IV
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Disodium Folinate
    Germany

  • Study on Shortened Anticoagulation with Rivaroxaban for Blood Clot Prevention in Patients Undergoing Hip Replacement Surgery

    Recruiting

    3 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Rivaroxaban
    Austria Germany

  • Study Comparing Sacituzumab Govitecan Alone and with Pembrolizumab for Patients with Low-Risk, Triple-Negative Early Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer female
    • Breast cancer male
    • Breast cancer stage I
    Investigated Drugs:
    • Pembrolizumab
    • Sacituzumab Govitecan
    Germany

  • Study on Durvalumab for Patients with High-Risk Endometrial Cancer After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    Investigated Drugs:
    • Durvalumab
    Belgium Czechia France Germany Italy The Netherlands

  • Study Comparing Trastuzumab Deruxtecan with a Drug Combination for Patients with HER2+ Early Breast Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Trastuzumab Deruxtecan
    Germany

  • Study Comparing Short Course Radiotherapy and Chemoradiotherapy with Fluorouracil, Calcium Folinate, and Capecitabine for Intermediate and High-Risk Rectal Cancer Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Capecitabine
    • Fluorouracil
    Germany

  • Study Comparing Ribociclib and Endocrine Therapy to Chemotherapy for Patients with Intermediate-Risk HR+/HER2- Early Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ribociclib
    Germany

  • Study Comparing FOLFOX Before Surgery to Risk-Adapted Chemotherapy After Surgery for Patients with Locally Advanced Rectal Cancer and Low Risk of Local Failure

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate Pentahydrate
    • Capecitabine
    • Fluorouracil
    Germany
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!